Actively Recruiting
Evaluation of Different Diagnostic and Therapeutic Strategies in Patients with Thyroid Pathology Observational Study
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-17
5850
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate different diagnostic and therapeutic strategies for patients with various thyroid conditions, including hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodules, and thyroid carcinoma. It is an observational, single-center study with both retrospective and prospective phases, conducted by the IRCCS Azienda Ospedaliero-Universitaria di Bologna. The study includes patients diagnosed from January 1, 1995, onward and follows them for up to 20 years to gather comprehensive data on thyroid disease management. The study includes two groups: a retrospective group with about 2850 patients diagnosed before the study approval and a prospective group enrolling about 3000 patients over 10 years after the study approval. Patients will not undergo any procedures beyond their usual clinical care. Data collected will reflect routine clinical practice without additional laboratory or instrumental exams specifically for the study. Participants will be monitored through standard clinical visits and assessments regularly conducted in daily practice. Researchers will collect clinical variables commonly recorded by physicians to characterize the patient population and compare different therapies and diagnostic approaches over an average follow-up of 17 years. The study also evaluates various treatment outcomes, drug effects, and prognostic factors related to thyroid diseases throughout the long follow-up period.
CONDITIONS
Brief Title
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age older than 18 years at the time of diagnosis
- Diagnosis of hypothyroidism, hyperthyroidism/thyrotoxicosis, benign thyroid nodule, or thyroid carcinoma
- Diagnosis made at this center or another center from 01/01/1995 onward (retrospective) or within 10 years after study approval (prospective)
- Provided informed consent to participate
You will not qualify if you...
- Follow-up lasting less than 3 months
- Incomplete or missing clinical data that affect proper patient assessment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 20 years
Participants who have thyroid pathology are observed through routine clinical care. Clinical variables commonly collected in daily practice will be recorded without additional procedures beyond normal care.
Regular visits as part of routine clinical care
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy, 40138
Actively Recruiting
Research Team
U
Uberto Pagotto, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here